Stryker Asks High Court To Allow More Leeway In Awarding Triple Damages
This article was originally published in The Gray Sheet
Executive Summary
The device firm's opening brief in a Supreme Court patent case says a two-part test for enhanced damages imposed by the Federal Circuit is unconstitutional and should be struck down in place of greater judge discretion.
You may also be interested in...
High Court To Hear Stryker Patent Case On Willful Infringement Standards
The US Supreme Court will consider arguments on what standards should be met if an award in a patent violation case is to be increased due to willful infringement. A District Court judge tripled a $70 million award Stryker was granted against Zimmer for infringement in a jury trial, but the award was reduced on appeal.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.